26.80
-0.15
(-0.56%)
At close: 2:58:02 PM GMT+8
Key Executives
Key Executives Information Not Available
Enimmune corporation
No. 3, Section 1
Tanxing Road Tanzi District
Taichung City
Taiwan
- Sector:
- Healthcare
- Industry: Biotechnology
Description
Enimmune corporation operates as a biopharmaceutical Research and development, and marketing company in Taiwan. Its products include Tuberculin PPD RT23 SSI, an approved drug for tuberculin test to determine whether the patient is infected with tuberculosis. The company is also involved in the development of vaccines to prevent various infectious diseases, such as enterovirus, pneumonia, norovirus, dengue fever virus, Middle East respiratory syndrome coronavirus, etc. Enimmune corporation was founded in 2014 and is based in Taichung City, Taiwan.
Corporate Governance
Enimmune corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Recent Events Information Not Available
Related Tickers
6549.TWO TaiwanJ Pharmaceuticals Co., Ltd.
7.98
-2.80%
6709.TWO Advagene Biopharma Co., Ltd.
20.25
+0.25%
6696.TWO Lin BioScience, Inc.
131.50
+1.94%
6610.TWO TWi Biotechnology, Inc.
13.75
+0.73%
6580.TWO TaiRx, Inc.
26.00
+1.96%
6652.TWO Eusol Biotech Co.,Ltd.
7.77
-0.38%
4195.TWO Genomics BioSci & Tech. Co.,Ltd.
18.90
+2.16%
6892.TWO Taiwan Bio Therapeutics Co., Ltd
39.00
+0.13%
4178.TWO StemCyte International, Ltd.
35.15
+1.59%
4197.TWO Visgeneer Inc.
9.78
0.00%